Breaking News
Former White House Advisor: "Trump to Release $150 Trillion Endowment"
The Mayo Clinic just tried to pull a fast one on the Trump administration...
'Cyborg 1.0': World's First Robocop Debuts With Facial Recognition And 360° Camera Visio
Dr. Aseem Malhotra Joins Alex Jones Live In-Studio! Top Medical Advisor To HHS Sec. RFK Jr. Gives...
Top Tech News
Scientists reach pivotal breakthrough in quest for limitless energy:
Kawasaki CORLEO Walks Like a Robot, Rides Like a Bike!
World's Smallest Pacemaker is Made for Newborns, Activated by Light, and Requires No Surgery
Barrel-rotor flying car prototype begins flight testing
Coin-sized nuclear 3V battery with 50-year lifespan enters mass production
BREAKTHROUGH Testing Soon for Starship's Point-to-Point Flights: The Future of Transportation
Molten salt test loop to advance next-gen nuclear reactors
Quantum Teleportation Achieved Over Internet For The First Time
Watch the Jetson Personal Air Vehicle take flight, then order your own
Microneedles extract harmful cells, deliver drugs into chronic wounds
Pathway to radical longevity – Induced Tissue Regeneration explained
Full regeneration and immortalized cells exists in humans two weeks after conception.
There is work to re-activate those capabilities with adult cells.
The video and screenshots below are from the the CEO of AgeX Dr Michael West and another with Michael West talking with Dr. Aubrey de Grey, V.P. New Technology Discovery.
AgeX Therapeutics is a biotechnology company formed in 2017 as a subsidiary of BioTime, Inc (NYSE MKT: BTX). Its mission is to apply technology related to cell immortality and pluripotency to human aging and age-related disease. The Company's technology platform has three facets: Pluripotent stem cell-derived progenitor cell lines representing over 200 types of cells in the body (PureStem technology); HyStem matrices; and induced tissue regeneration (iTR) – the latter being an emerging technology directed at inducing the immortal regeneration of tissues in the body.